Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic releases all-in-one device in Europe:

This article was originally published in Clinica

Executive Summary

Medtronic has announced the European commercial release of its device for fast and slow heart rhythms. The Medtronic Jewel AF is an implantable arrhythmia management device that has both detection and therapeutic capabilities. Medtronic claims that the Jewel AF is the world's first device to deliver tiered atrial therapies and pacing. It will first be indicated for patients who suffer fast ventricular arrhythmias. The device is still under clinical evaluation in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel